is retatrutide a glp3 (GLP-3): The Triple Agonist Peptide — Research Overview – Emerald Peptides Retatrutide (GLP-3)

CrossRef CTTN overexpression on circulating tumor cells promotes hepatocellular carcinoma recurrence via enhancing the proliferation and clonality of circulating tumor cells Yongzhi Liu, Zhidong Fu, Lihui Jiang, Yang Chen, Feng Jiang, Chuanling Zhang, Tieming Zhu Cytotechnology .2026;[Epub] CrossRef Intra-tumoral microbiota: Key modulators of tumor immunity and therapeutic potential Junju He, Hui Tan, Yanru Qiu, Yuchao Dan, Qian Wan, Lan Li, Jie Wu, Qibin Song, Hongbin Chen, Bin Xu Genes & Diseases .2026

Other Florida Weight Loss Clinics Select a location below for details

If youre experiencing any symptoms that could be side effects of GLP-1s, contact your healthcare provider

Front Pharmacol 2021;12:678126

The most common effects are mild injection site reactions (temporary redness or slight discomfort), occasional mild water retention (often temporary and dose-dependent), rare reports of mild tingling or numbness in extremities (usually transient), mild increases in hunger in some subjects (less common than with GHRP-6), and occasional mild headaches (often resolve quickly)